Root Financial Partners
DNLI icon

Root Financial Partners’s Denali Therapeutics DNLI Stock Holding History

Root Financial Partners’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.45K Buy
+409
New +$9.6K ﹤0.01% 1995
2026
Q2 		– Sell
-188
Closed -$3.61K – 1138
2026
Q1 		$3.61K Buy
188
+88
+88% +$1.75K ﹤0.01% 2073
2025
Q4 		$1.65K Buy
100
+30
+43% +$506 ﹤0.01% 2021
2025
Q3 		$1.02K Buy
+70
New +$1.01K ﹤0.01% 2054

Other funds holding DNLI

Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Root Financial Partners's DNLI Position: Q3 2026 in Review

Root Financial Partners opened a new position in Denali Therapeutics (DNLI) in Q3 2026: 409 shares worth $8.45K. The stake represents ﹤0.01% of the portfolio and ranks #1995 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in DNLI as recently as Q1 2026.

Root Financial Partners first reported a position in DNLI in Q3 2025 and has held it in 4 quarters since. 108 funds tracked by Wall St. Rank hold DNLI as of Q3 2026.

  • Root Financial Partners held 409 shares of Denali Therapeutics worth $8.45K as of Q3 2026.
  • Denali Therapeutics was a new Root Financial Partners position in Q3 2026.
  • Denali Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #1995 holding.
  • Root Financial Partners first reported a position in Denali Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 108 funds tracked by Wall St. Rank held Denali Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.